These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 3292210)

  • 21. Therapeutic potential of herbal drugs in cerebral ischemia.
    Gupta YK; Briyal S; Gulati A
    Indian J Physiol Pharmacol; 2010; 54(2):99-122. PubMed ID: 21090528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular dysfunction in cerebrovascular disease: mechanisms and therapeutic intervention.
    Miller AA; Budzyn K; Sobey CG
    Clin Sci (Lond); 2010 Apr; 119(1):1-17. PubMed ID: 20370718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial.
    Chapman N; Huxley R; Anderson C; Bousser MG; Chalmers J; Colman S; Davis S; Donnan G; MacMahon S; Neal B; Warlow C; Woodward M;
    Stroke; 2004 Jan; 35(1):116-21. PubMed ID: 14671247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Controlled clinical trials in stroke.
    Fieschi C; Frontoni M; Argentino C; Orzi F; Toni D; Millefiorini E; Carolei A; Cavalletti C
    Arzneimittelforschung; 1991 Mar; 41(3A):344-7. PubMed ID: 1859506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Limiting neurological damage after stroke: a review of pharmacological treatment options.
    Read SJ; Hirano T; Davis SM; Donnan GA
    Drugs Aging; 1999 Jan; 14(1):11-39. PubMed ID: 10069406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does the preventive effect of different drugs depend on location of the atherosclerotic process?
    Poredos P; Jezovnik MK
    Int Angiol; 2008 Aug; 27(4):274-80. PubMed ID: 18677288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is magnesium neuroprotective following global and focal cerebral ischaemia? A review of published studies.
    Meloni BP; Zhu H; Knuckey NW
    Magnes Res; 2006 Jun; 19(2):123-37. PubMed ID: 16955724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Neuroprotection by aspirin in cerebrovascular pathology].
    Lorenzo Fernández P
    An R Acad Nac Med (Madr); 2002; 119(2):311-20; discussion 320-6. PubMed ID: 12518657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medical treatment of acute ischemic stroke.
    Besson G; Bogousslavsky J
    J Cardiovasc Pharmacol; 1991; 18 Suppl 8():S6-9. PubMed ID: 1726734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug therapy of neurovascular disease.
    Weinberger J; Frishman WH; Terashita D
    Cardiol Rev; 2003; 11(3):122-46. PubMed ID: 12705843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative neuroimaging for the evaluation of the effect of stroke treatment.
    Heiss WD; Graf R; Grond M; Rudolf J
    Cerebrovasc Dis; 1998 Mar; 8 Suppl 2():23-9. PubMed ID: 9570023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preconditioning and postconditioning: underlying mechanisms and clinical application.
    Hausenloy DJ; Yellon DM
    Atherosclerosis; 2009 Jun; 204(2):334-41. PubMed ID: 19081095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pentoxifylline (oxpentifylline). A review of its therapeutic efficacy in the management of peripheral vascular and cerebrovascular disorders.
    Frampton JE; Brogden RN
    Drugs Aging; 1995 Dec; 7(6):480-503. PubMed ID: 8601054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nimodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease.
    Langley MS; Sorkin EM
    Drugs; 1989 May; 37(5):669-99. PubMed ID: 2663415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of antithrombotic drugs in artery disease.
    Gallus AS
    Clin Haematol; 1986 May; 15(2):509-59. PubMed ID: 3524934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The stroke therapy research boom: implications for the hospital formulary.
    Bender NK
    Pharmacotherapy; 1998; 18(3 Pt 2):108S-115S; discussion 85S-86S. PubMed ID: 9619495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin II type 1 receptors in cerebral ischaemia-reperfusion: initiation of inflammation.
    Schulz R; Heusch G
    J Hypertens Suppl; 2006 Mar; 24(1):S123-9. PubMed ID: 16601565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiplatelet therapy in cerebrovascular disorders.
    Weber R; Brenck J; Diener HC
    Handb Exp Pharmacol; 2012; (210):519-46. PubMed ID: 22918745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen and cerebrovascular regulation in menopause.
    Raz L
    Mol Cell Endocrinol; 2014 May; 389(1-2):22-30. PubMed ID: 24472522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebral microcirculatory disturbances of stroke prone spontaneously hypertensive rats with acute stroke and mechanism of treatment.
    Zhai QH; Duan CG
    Chin Med J (Engl); 1993 Jul; 106(7):518-21. PubMed ID: 7694826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.